Naomi McGregor

Newcastle University — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

6h-index128citations22works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(6), PARP inhibition in cancer therapy(5), Gut microbiota and health(4), Ovarian cancer diagnosis and treatment(4), BRCA gene mutations in cancer(3)

Publications22 total

P0070 Improvement in quality of life in inflammatory bowel disease patients treated with advanced therapies: Interim findings from IBD-RESPONSE
Journal of Crohn s and Colitis·2026
P0068 Clinical, demographic and technical drivers of the IBD microbiome: an interim baseline analysis of the IBD-RESPONSE study
Journal of Crohn s and Colitis·2026
P0184 Improvement in fatigue but not joint pain and stiffness in Inflammatory Bowel Disease patients treated with advanced therapies: Interim findings from IBD-RESPONSE
Journal of Crohn s and Colitis·2026
P1045 The impact of patient and public involvement and engagement (PPIE) on the design and operationalisation of a multi-centre inception cohort study: Insights from Open-IBD
Journal of Crohn s and Colitis·2026
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): results from an internal pilot randomised controlled trial
Pilot and Feasibility Studies·2025Open Access
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): Results from an internal pilot randomised controlled trial
2025Open Access
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension: CONFORM-OH pilot RCT and economic evaluation
Health Technology Assessment·2025Open Access
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research
EBioMedicine·2024· 2 citedOpen Access
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials
BMJ Open·2024· 10 citedOpen Access
P143 Evaluating intestinal biopsy preservation and storage methods to facilitate large-scale microbiome research in inflammatory bowel disease (IBD)
Poster presentations·2024
Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves’ disease
BMJ Open·2024Open Access
Quantifying the carbon footprint of academic clinical trials: building the evidence base and hotspot identification
2024· 2 citedOpen Access
Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine
BMJ Open·2024· 11 citedOpen Access
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer
British Journal of Cancer·2024· 20 citedOpen Access
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma
Cancer Cell·2023· 43 citedOpen Access
Quantifying the carbon footprint of clinical trials: guidance development and pilot study
Research Square (Research Square)·2023· 1 citedOpen Access
722O Randomised phase II trial of olaparib compared to weekly paclitaxel or olaparib plus cediranib in patients with platinum-resistant ovarian cancer (OCTOVA)
Annals of Oncology·2021· 14 cited
Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol
BMJ Open·2021· 16 citedOpen Access
Trial of different drug and treatment combinations for patients with inherited genetic changes who are considering further therapy to treat their ovarian cancer
http://isrctn.com/·2018Open Access
Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit
Trials·2017· 5 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Dean Allerton(7), Victoria Hildreth(7), Ruth Wood(6), Luke Jostins-Dean(6), Hannah Watson(5), Robert Lees(5), Julian R. Marchesi(5), James Wason(5), Shibani Nicum(4), Linda Collins(4), Emma Clark(4), Katherine Frith(4), Helen Hancock(4), Sarah T. Lawrence(4), Georgina Bates(4), C Cotobal Martin(4), C J Stewart(4), Sam T. Dobbie(3), Mark R. Middleton(3), Iain A. McNeish(3)